跳至主要内容
临床试验/NL-OMON55673
NL-OMON55673已完成不适用

Effect of Iron deficiency on skeletetal muscle metabolisme in HFpEF - Iron Muscles

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • All patients: presence of heart failure with preserved ejection fraction
  • (HFpEF) according to ESC guidelines: (1) signs and/or symptoms of heart failure
  • (2) LVEF >= 50%, (3) elevated levels of natriuretic peptide, (4) relevant
  • structural heart disease (LVmass index >95 in women, >115 in men; or LA
  • enlargement, LAVI >34 ml/m2), or diastolic dysfunction (E/e' >= 13, or e'<9).
  • Patients with Iron deficiency: serum ferritin < 100 µg/L or serum ferritin
  • between 100-299 µg/L in combination with a transferrin saturation < 20%.

排除标准

  • - any iron supplement during last 6 months prior to inclusion
  • - any chemotherapy in last year
  • - significant peripheral artery disease
  • - contra indication for CMR, such as metallic implant, pacemaker/ICD or
  • claustrophobia, body weight >130kg.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

Effect of Iron deficiency on skeletetal muscle... | 临床试验